Read our latest news, and find more about us and our portfolio companies.

Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology

Merck KGaA, Darmstadt, Germany and Artios will conduct collaborative research and Merck KGaA, Darmstadt, Germany shall have the right to opt into exclusive development and commercialization of compounds on up to 8 targets

Ferroelectric Memory GmbH (FMC) Raises $20 Million to Accelerate Next-Generation Memory for AI, IoT, Edge Computing, and Data Center Applications

Strong investor syndicate will enable FMC to accelerate commercialization of its disruptive non-volatile ferroelectric memory technology for a broad set of memory and compute applications

Calypso Biotech announces successful dosing of first Phase 1 cohort with anti-Interleukin-15 (IL-15) monoclonal antibody CALY-002 for the treatment of Autoimmune Diseases

Dose-escalation study to evaluate safety, biological and early clinical effect of CALY-002 in healthy volunteers and patients with Celiac Disease and Eosinophilic Esophagitis

Soteria Biotherapeutics Announces Scientific Advisory Board

Soteria Biotherapeutics, Inc. today announced the formation of a scientific advisory board to help guide the company's early stage research and development.

Xilio Therapeutics Presents Promising Preclinical Tumor-Selective Efficacy and Safety Data for XTX201 (IL-2) and XTX101 (anti-CTLA-4) at SITC

Xilio Therapeutics today announced the presentation of preclinical data of its lead investigational therapies at the 35th Annual Meeting of The Society for Immunotherapy of Cancer (SICT 2020).

Galecto Announces Pricing of Initial Public Offering

Galecto, Inc. today announced the pricing of its initial public offering of 5,666,667 shares of common stock at a public offering price of $15.00 per share.

STORM Therapeutics selects first-in-class clinical candidate targeting METTL3

STORM Therapeutics today announces that STC-15, its first-in-class drug candidate targeting METTL3, has been selected for development towards first in human clinical studies

Synthetic Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering

NanoSyrinx is the first company to engineer ‘nanosyringes’, a selective non-viral peptide and protein delivery system identified in an undisclosed organism. The company will focus on direct cytosolic delivery of genome editing enzymes and therapeutic proteins in vivo, with key applications in the cell and gene therapy space.

Mosa Meat raises Series B funding to prepare for large-scale cultured meat production

Mosa Meat announced the first closing of $55M as part of a larger Series B funding round

Galecto Raises $64 Million to Accelerate Development of Clinical Pipeline

Funds will support preparations for potential EU conditional approval of GB0139 in IPF and multiple new Phase 2 clinical trials

Rapid prototyping and validation of SARS-CoV-2 clinical diagnostic workflows

From design to prototyping, validation, and frontline diagnostic testing in nine weeks

Sonde Health purchases NeuroLex Labs’ voice platform and 500K biometric samples

Sonde Health acquires NeuroLex Laboratories, Inc. to forms one of the world’s preeminent biobanks focused on vocal biomarkers

DNA Script Expands Series B to $89M

Casdin Capital leads the $50M extension; funding will support commercial launch of SYNTAX™️ — the world’s first enzymatic DNA printer.

Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors

Mr. Clancy brings significant strategic, financial and operational leadership experience in the biotechnology and pharmaceutical industry

Synaffix Announces Third Deal Expansion by ADC Therapeutics

Synaffix B.V. announces that ADC Therapeutics SA has expanded its existing collaboration to explore additional applications, including DAR1, of Synaffix’ site-specific conjugation technologies

Sonde Health Launches New Voice-Enabled Health Screening Tool to Help Employers Return to Work During the Global Pandemic

Sonde One combines 6-second voice analysis, COVID-19 questionnaire, and body temperature reading in one app

Micropsi Industries Secures Two New Specialized Investors

Our Existing Backers Will Also Supply Fresh Investment

Akili Announces FDA Clearance of EndeavorRx™ for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game

Shown to improve attention function, EndeavorRx is backed by data from five clinical studies, including a prospective, randomized controlled trial

Computers modelled on the human brain

Comment from Kai Beckmann, member, executive board, Merck KGaA

Galecto Appoints New Chair and Strengthens Board of Directors

Appoints Amit Munshi as Chair, deeply experienced industry executive, CEO of Arena Pharmaceuticals

Xilio Therapeutics Appoints Martin H. Huber, M.D as Chief Medical Officer

To Lead XTX201 (Tumor-Selective IL-2) and XTX101 (Tumor-Selective aCTLA-4) into the Clinic while Xilio Continues to Advance its Tumor-Selective Cytokine Pipeline

Akili Announces ENDEAVORTM Digital Attention Treatment is Now Available for Children with Attention Deficit Hyperactivity Disorder (ADHD) under FDA’s COVID-19 Enforcement Discretion Guidance

ENDEAVORTM (AKL-T01) is now available for use by children with attention deficit hyperactivity disorder (ADHD) and their families

FoRx Therapeutics AG Raises EUR 10 Million Seed Round

First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer Seasoned Biotech Executive Colin Goddard Joins as Executive Chairman

Seeqc Gains Over $11 Million in Funding to Introduce Fully Digital Quantum Computing

Spinout Announces Investment From M Ventures, the Strategic, Corporate Venture Capital Arm of Merck KGaA, Darmstadt, Germany, to Deliver Scalable, Energy-Efficient Quantum Computing Systems

Scipio bioscience raises €6.0 M Series A financing

To develop and launch a kit dedicated to sample preparation for single-cell RNAsequencing

Artios Pharma Strengthens Clinical Development Team with Senior Appointments

Artios Pharma Limited today announces the appointment of Bryony Harrop as Vice President (VP) of Clinical Development

iOnctura Expands its Clinical Advisory Board

iOnctura SA announces the addition of new members to its Clinical Advisory Board (CAB)

First programmable memristor computer aims to bring AI processing down from the cloud

Circuit elements that store information in their electrical resistances enable a brain-like form of computing, storing and processing information in the same place